Sponsored By
Innophos To Acquire Novel Ingredients To Create Nearly Half Billion Nutrition PlatformInnophos To Acquire Novel Ingredients To Create Nearly Half Billion Nutrition Platform
Innophos Holdings, Inc. announced today that it has entered into a definitive merger agreement to acquire Novel Ingredients, a New Jersey-based provider of dietary supplement ingredient solutions primarily owned by GenNx360 Capital Partners, a New York-based private equity firm.
August 1, 2017
1 Min Read
.png?width=850&auto=webp&quality=95&format=jpg&disable=upscale)
Innophos Holdings, Inc. announced today that it has entered into a definitive merger agreement to acquire Novel Ingredients, a New Jersey-based provider of dietary supplement ingredient solutions primarily owned by GenNx360 Capital Partners, a New York-based private equity firm.
Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.
You May Also Like